Home › NDC Lookup › RxCUI directory › RxCUI 1601097

Capsaicin 0.000325 MG/MG / lidocaine hydrochloride 0.04 MG/MG / menthol 0.1 MG/MG / methyl... — RxCUI 1601097

RxNorm drug concept · Semantic branded drug
RxCUI 1601097 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1601097
Official nameCapsaicin 0.000325 MG/MG / lidocaine hydrochloride 0.04 MG/MG / menthol 0.1 MG/MG / methyl salicylate 0.275 MG/MG Topical Ointment [LidoPro]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asLidoPro (capsaicin 0.0325 % / lidocaine HCl 4 % / menthol 10 % / methyl salicylate 27.5 % ) Topical Ointment; LidoPro 0.0325 % / 4 % / 10 % / 27.5 % Topical Ointment
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Lidocaine Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • This patch is used to treat post-herpetic neuralgia — that's the persistent burning or aching nerve pain that sometimes sticks around after a shingles outbreak, even after the rash...
  • What is this patch actually for — why did my doctor prescribe it?
  • You wear it for up to 12 hours, then take it off for the next 12 hours — think of it as '12 hours on, 12 hours off.' Your prescriber may allow up to 3 patches at a time, but never...
  • How long do I wear the patch, and can I wear more than one?
📖 Read our full Lidocaine Transdermal Patch guide →

🕸️ Concept Web — How Capsaicin 0.000325 MG/MG / lidocaine hydrochlori... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Capsaicin 0.000325 MG/MG / lidocaine hydrochloride 0.04 MG/MG / menthol 0.1 MG/MG / methyl salicylate 0.275 MG/MG Topical Ointment [LidoPro] RxCUI 1601097

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 6

    The active substance itself — no strength, form, or brand attached yet.

    • Capsaicin 1992
    • Lidocaine 6387
    • Menthol 6750
    • Methyl salicylate 29787
    • Capsaicin / lidocaine / menthol / methyl salicylate 1020419
    • Lidocaine hydrochloride 142440
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • LidoPro 1425506
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Capsaicin / lidocaine / menthol / methyl salicylate Topical Ointment 1361409
    • Capsaicin / lidocaine hydrochloride / menthol / methyl salicylate Topical Ointment 2648927
    • Capsaicin / lidocaine / menthol / methyl salicylate Topical Product 1155432
    • Capsaicin / lidocaine hydrochloride / menthol / methyl salicylate Topical Product 2659196
    • Capsaicin / lidocaine / menthol / methyl salicylate Topical Ointment [LidoPro] 1425508
    • Capsaicin / lidocaine hydrochloride / menthol / methyl salicylate Topical Ointment [LidoPro] 2655015
    • LidoPro Topical Product 1425509
    • Topical Ointment 316985
    • +1 more in this family
  4. Clinical & branded drugs 6

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 21 of 22 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Capsaicin 0.000325 MG/MG / lidocaine hydrochloride 0.04 MG/MG / menthol 0.1 MG/MG / methyl salicylate 0.275 MG/MG Topical Ointment SCD · 1601095
  • Capsaicin 0.000325 MG/MG SCDC · 1361406
  • Lidocaine hydrochloride 0.04 MG/MG SCDC · 1010076
  • Menthol 0.1 MG/MG SCDC · 384557
  • Methyl salicylate 0.275 MG/MG SCDC · 1361408
  • Capsaicin / lidocaine / menthol / methyl salicylate Topical Ointment SCDF · 1361409
  • Capsaicin / lidocaine hydrochloride / menthol / methyl salicylate Topical Ointment SCDFP · 2648927
  • Capsaicin / lidocaine / menthol / methyl salicylate Topical Product SCDG · 1155432
  • Capsaicin / lidocaine hydrochloride / menthol / methyl salicylate Topical Product SCDGP · 2659196

Brand-Name Concepts

  • Capsaicin 0.000325 MG/MG / lidocaine hydrochloride 0.04 MG/MG / menthol 0.1 MG/MG / methyl salicylate 0.275 MG/MG [LidoPro] SBDC · 1601096
  • Capsaicin / lidocaine / menthol / methyl salicylate Topical Ointment [LidoPro] SBDF · 1425508
  • Capsaicin / lidocaine hydrochloride / menthol / methyl salicylate Topical Ointment [LidoPro] SBDFP · 2655015
  • LidoPro Topical Product SBDG · 1425509
  • LidoPro BN · 1425506

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 1601097 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
68788-8314-01 92 g in 1 BOTTLE (68788-8314-1) LidoPro Preferred Pharmaceuticals Inc. 2022-07-08
68788-8833-09 1 TUBE, WITH APPLICATOR in 1 BOX (68788-8833-9) / 9900 mg i... LidoPro Pain Relief Preferred Pharmaceuticals Inc. 2025-02-21
Observed labelers: Preferred Pharmaceuticals Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.